To evaluate the effect of the selective HDAC6 inhibitor WT161 on acute lymphoblastic leukemia (ALL), we first examined HDAC6 expression in four ALL cell lines (BALL-1, NALM-6, Jurkat, and MOLT-4). This evidence concerns the gene HDAC6 and acute lymphoblastic leukemia.